Retinal Dystrophy
Ophthalmology·MeSH: Retinal Dystrophies
4 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| luxturna | Spark Therapeutics, Inc. (SPARK) |
Phase 3(2)
Phase 1(1)
| Drug | Company |
|---|---|
| lx101 | SAB BIOTHERAPEUTICS, INC. (SABS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Retinal Dystrophy?
BioSniper tracks 4 drugs in development for Retinal Dystrophy across 3 companies.
How many clinical trials target Retinal Dystrophy?
There are 1 clinical trial targeting Retinal Dystrophy tracked by BioSniper.
Deep-dive into Retinal Dystrophy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis